INTEGRATED BIOPHARMA INC Net Income (Loss) Available to Common Stockholders, Diluted
INTEGRATED BIOPHARMA INC (INBP) reported Net Income (Loss) Available to Common Stockholders, Diluted of $926.00 thousand for the 3-month period ending 2012-12-31, per its 10-Q filed 2013-02-19.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2013-02-19
- INTEGRATED BIOPHARMA INC net income (loss) available to common stockholders, diluted for the quarter ending 2012-12-31 was $926.00K.
- INTEGRATED BIOPHARMA INC net income (loss) available to common stockholders, diluted for the quarter ending 2011-12-31 was -$785.00K.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month |
|---|---|---|
| 2012-12-31 | $926.00K 10-Q · filed 2013-02-19 | -$155.00K 10-Q · filed 2013-02-19 |
| 2011-12-31 | -$785.00K 10-Q · filed 2013-02-19 | -$422.00K 10-Q · filed 2013-02-19 |